Valuation : Cegedim

Market Cap 14Cr 16Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 157.85Cr 61Cr 799.26Cr 62Cr 61Cr 2.57TCr P/E 2026 *
6.78x
P/E 2027 * 5.17x
Enterprise Value 30Cr 35Cr 29Cr 26Cr 49Cr 3.34TCr 49Cr 338.13Cr 131.21Cr 1.71TCr 132.72Cr 129.82Cr 5.52TCr EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 16Cr
+3.08%+5.26%-31.80%+28.07% 46TCr
+0.05%-2.95%-18.65%+44.77% 25TCr
-2.97%-2.38%-22.71%+18.28% 15TCr
-1.39%+12.17%-57.48%+308.88% 5.49TCr
-0.57%-4.41%-34.26%+6.85% 4.63TCr
-16.68%-19.18%-39.15%+4.43% 2.01TCr
+0.06%-3.41%-17.64%+56.67% 1.96TCr
-1.05%-2.52%-26.34%+11.22% 1.39TCr
-19.93%-21.10%-37.70%+88.71% 1.35TCr
Average -3.94%-2.50%-31.75%+63.10% 11.34TCr
Weighted average by Cap. +0.26%+1.31%-28.66%+45.53%

Financials

2026 *2027 *
Net sales 66Cr 77Cr 62Cr 57Cr 106.04Cr 7.24TCr 106.33Cr 733.28Cr 284.55Cr 3.71TCr 287.82Cr 281.54Cr 12TCr 68Cr 79Cr 64Cr 59Cr 109.98Cr 7.51TCr 110.28Cr 760.52Cr 295.12Cr 3.85TCr 298.51Cr 292Cr 12TCr
Net income 2.13Cr 2.48Cr 2Cr 1.83Cr 3.42Cr 233.71Cr 3.43Cr 24Cr 9.19Cr 119.91Cr 9.3Cr 9.09Cr 386.29Cr 2.8Cr 3.25Cr 2.63Cr 2.41Cr 4.5Cr 307.22Cr 4.51Cr 31Cr 12Cr 157.63Cr 12Cr 12Cr 507.8Cr
Net Debt 16Cr 19Cr 15Cr 14Cr 26Cr 1.78TCr 26Cr 180.28Cr 70Cr 912.82Cr 71Cr 69Cr 2.94TCr 13Cr 16Cr 13Cr 11Cr 22Cr 1.47TCr 22Cr 148.7Cr 58Cr 752.94Cr 58Cr 57Cr 2.43TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-